Moriah Psalm Barboza, NP

Moriah Barboza practices at Orchard Creek Surgery Center - Mountain View in Mountain View, California.

Moriah Barboza's NPI, 1417110347, was assigned on July 10, 2008. Moriah Barboza holds California license 18237.

Moriah Barboza's primary practice is Orchard Creek Surgery Center - Mountain View, at 525 South Drive, Suite 115, Mountain View, CA 94040. The practice phone is (650) 969-5600.

Moriah Barboza's primary practice is Orchard Creek Surgery Center - Mountain View in Mountain View, California. The medical group on file is Schweiger Dermatology Group, San Pedro. Dmand AI also links Moriah Barboza to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Moriah Barboza practices, 2 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Moriah Barboza's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Moriah Barboza is licensed in California.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, head wound, joint cyst and minor head injury among the conditions Moriah Barboza treats.

CMS data shows 7,982 Medicare services from Moriah Barboza across 19 procedure codes in 2024, for 1,041 Medicare patients. Medicare paid $269,818 for them. Every service was in an office.

CMS counts 1,041 Medicare patients who saw Moriah Barboza in 2024. The largest group is 75 to 84, with 503 patients. 75% of them have high cholesterol, and 72% have high blood pressure. Their average risk score is 1.19, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Moriah Barboza's median patient age at 78, with 55% women.

In 2024, Moriah Barboza wrote 137 Medicare Part D claims for 101 patients. 98% of them were for generic drugs. CMS names the drug for 91 of them, across 4 drugs with 11 or more claims each, at $1,197 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Moriah Barboza for performance year 2024, reported as part of a group. Moriah Barboza accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Moriah Barboza from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $18.